New Drugs at Generics' Price: Pipe Dream or Possibility?

As I reported for this story on Piramal Healthcare’s full-throttle effort in developing new molecule drugs, one thing that repeatedly came up for discussion was the cost. How much does it actually cost to produce a new drug? Are pharma companies (read big pharma) in the business for disease management or profit management? Well, the […]

New Drugs at Generics’ Price: Pipe Dream or Possibility?

As I reported for this story on Piramal Healthcare’s full-throttle effort in developing new molecule drugs, one thing that repeatedly came up for discussion was the cost. How much does it actually cost to produce a new drug? Are pharma companies (read big pharma) in the business for disease management or profit management? Well, the […]

Biocon-Pfizer Breakup: Why Diabetes Alliances Don't Work for Indian pharma?

In a very surprising move, Pfizer and Biocon announced today that they have called off their 17-month old commercialization alliance for generic insulin. “The companies have agreed that due to the individual priorities for their respective biosimilars businesses, it is in their best interest to move forward independently,” said the press release. This was followed […]

Biocon-Pfizer Breakup: Why Diabetes Alliances Don’t Work for Indian pharma?

In a very surprising move, Pfizer and Biocon announced today that they have called off their 17-month old commercialization alliance for generic insulin. “The companies have agreed that due to the individual priorities for their respective biosimilars businesses, it is in their best interest to move forward independently,” said the press release. This was followed […]